Literature DB >> 11425039

Granulocyte/macrophage colony-stimulating factor plays an essential role in oxidized low density lipoprotein-induced macrophage proliferation.

T Biwa1, M Sakai, M Shichiri, S Horiuchi.   

Abstract

We and other groups have recently demonstrated that oxidized low density lipoprotein (Ox-LDL) induces proliferation of macrophages in vitro. Since previous immunohistochemical studies demonstrated that macrophages and macrophage derived foam cells proliferated in situ in atherosclerotic lesions, it seems reasonable to expect that the Ox-LDL-induced macrophage proliferation might be linked to the development of atherosclerotic lesions. Thus, clarification of the molecular cascades of Ox-LDL-induced macrophage proliferation is expected to enhance our knowledge of the pathogenesis of atherosclerosis. Recently, we demonstrated that the activation of PKC leads to release into the culture medium of granulocyte/macrophage colony-stimulating factor (GM-CSF) which plays an important role in Ox-LDL-induced macrophage proliferation. In this review article, we mainly show the role of GM-CSF in the Ox-LDL-induced macrophage proliferation. Moreover, based on our recent findings, we summarize the Ox-LDL-induced signaling pathway for macrophage proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11425039     DOI: 10.5551/jat1994.7.14

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  7 in total

1.  Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages.

Authors:  Yashaswini Kannan; Kruthika Sundaram; Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy; Mark D Wewers
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

2.  Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit.

Authors:  Shahida Shafi; David Lamb; Helmout Modjtahedi; Gordon Ferns
Journal:  Int J Exp Pathol       Date:  2009-12-11       Impact factor: 1.925

Review 3.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

4.  Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis.

Authors:  James D Chang; Galina K Sukhova; Peter Libby; Eugenia Schvartz; Alice H Lichtenstein; Seth J Field; Caitlin Kennedy; Swetha Madhavarapu; Ji Luo; Dianqing Wu; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

5.  Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition.

Authors:  Lauren A Biwer; Karen M D'souza; Ali Abidali; Danni Tu; Ashley L Siniard; Matthew DeBoth; Matthew Huentelman; Taben M Hale
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

6.  PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.

Authors:  Teresa M Zotes; Cristina F Arias; José J Fuster; Roberto Spada; Sonia Pérez-Yagüe; Emilio Hirsch; Matthias Wymann; Ana C Carrera; Vicente Andrés; Domingo F Barber
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.

Authors:  Torben Mentrup; Kosta Theodorou; Florencia Cabrera-Cabrera; Andreas O Helbig; Kathrin Happ; Marion Gijbels; Ann-Christine Gradtke; Björn Rabe; Akio Fukumori; Harald Steiner; Andreas Tholey; Regina Fluhrer; Marjo Donners; Bernd Schröder
Journal:  J Exp Med       Date:  2019-02-28       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.